Envista Holdings is trading at $24.38, up +4.05%, with no clear company-specific catalyst identified for September 22, 2026.

  • Recent coverage highlights the September 15 healthcare conference and September 18 analyst actions, including Stifel’s Buy reiteration and UBS’s target cut; neither directly explains today’s move.
  • Broader markets are mixed, so the gain cannot be confidently attributed to market-wide momentum.